14 November is World Diabetes Day

Diabetes can impact people across all life stages, including childhood, the reproductive years, working age and older adulthood.

The theme of this year’s WHO World Diabetes Day, "Diabetes across life stages,” recognizes that every person living with diabetes should have access to integrated care, supportive environments and policies that promote health, dignity and self-management. This campaign emphasizes the importance of a life-course approach to diabetes prevention, management and overall well-being. 

Our key messages include:

1. Diabetes can affect people at every stage of life;
2. From childhood to older age, diabetes prevention and care efforts must be integrated across life stages; and
3. Supporting well-being and self-care empowers people with diabetes at every age.
   

World Diabetes Day provides an opportunity to raise awareness about diabetes as a critical global public health issue. Join us in raising awareness, spreading knowledge and creating lasting change for all affected by diabetes.

In 2022, WHO Member States endorsed 5 global diabetes coverage targets to be achieved by 2030:

• 80% of people with diabetes are diagnosed;
• 80% of people with diagnosed diabetes have good control of glycaemia;
• 80% of people with diagnosed diabetes have good control of blood pressure;
• 60% of people with diabetes of 40 years or older receive statins; and 
• 100% of people with type 1 diabetes have access to affordable insulin and blood glucose self-monitoring.

News

• Solomon Islands health facilitators strengthen regional fight against diabetes 
• Hope at every step: Diabetes and diabetic foot care in Solomon Islands 
• PAHO/WHO Bahamas Reinforces Support for Children with Type 1 Diabetes Through Mental Health Advocacy 
• PAHO/WHO supports Kids with Diabetes Summer Camp 
• Sale of energy drinks to minors banned in Kazakhstan in bold public health move 
• WHO updates list of essential medicines to include key cancer, diabetes treatments 
• Meeting of the Guideline Development Group for the monitoring and management of hyperglycaemia in pregnancy